Alba, A <br/><br/>
Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.  [electronic resource] 

 -  Clinical and experimental immunology  Mar 2008 
 - 467-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2007.03580.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>B-Lymphocytes--immunology<br/>Cytokines--metabolism<br/>Diabetes Mellitus, Type 1--immunology<br/>Disease Models, Animal<br/>Disease Progression<br/>G(M1) Ganglioside--immunology<br/>Interferon-beta--immunology<br/>Islets of Langerhans--immunology<br/>Killer Cells, Natural--immunology<br/>Lymph Nodes--immunology<br/>Lymphocyte Subsets--immunology<br/>Mice<br/>Mice, Inbred NOD